Infantile neuroaxonal dystrophy

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:35069OMIM:256600G23.0
Who is this for?
Show terms as
1FDA treatments36Active trials61Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Infantile neuroaxonal dystrophy (INAD), also known as Seitelberger disease, is a rare and serious brain disorder that begins in early childhood. It belongs to a group of conditions called neurodegeneration with brain iron accumulation (NBIA). In INAD, the nerve fibers that carry signals throughout the body become damaged. Tiny abnormal swellings, called axonal spheroids, build up in the nervous system and cause it to stop working properly over time. Children with INAD usually develop normally for the first year or two of life, then begin to lose skills they had already learned. The disease affects movement, muscle tone, vision, and thinking. Most children experience progressive muscle weakness, loss of the ability to walk, and eventually loss of speech and the ability to interact with their surroundings. Vision problems, including damage to the optic nerve, are also very common. There is currently no cure for INAD. Treatment focuses on keeping children as comfortable as possible, managing symptoms, and supporting quality of life. This includes physical therapy, feeding support, seizure management, and palliative care. Research into gene therapy and other targeted treatments is ongoing, giving families and researchers hope for the future.

Also known as:

Key symptoms:

Loss of previously learned motor skills such as walking or sittingMuscle weakness and low muscle tone (floppiness)Stiff or spastic muscles over timeLoss of speech and communicationVision problems and gradual vision lossRapid, involuntary eye movements (nystagmus)SeizuresDifficulty swallowing and feeding problemsLoss of bladder and bowel controlIntellectual decline and loss of awareness of surroundingsBreathing difficulties in later stagesCrossed eyes (strabismus)

Clinical phenotype terms (50)— hover any for plain English
Psychomotor deteriorationHP:0002361Progressive spasticityHP:0002191Eye of the tiger anomaly of globus pallidusHP:0002454Bulbar signsHP:0002483Abnormality of peripheral nerve conductionHP:0003134Diffuse axonal swellingHP:0003405
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Infantile

Begins in infancy, roughly 1 month to 2 years old

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

10 events
Jul 2026ADVANCE-FORSEE. ADVANCEd Video Monitoring FOR Early Signaling of Adverse Events and Optimal dischargE Planning.

Catharina Ziekenhuis Eindhoven

TrialNOT YET RECRUITING
Jun 2026Chicago Data-driven Opioid Use Disorder Screening, Engagement, Treatment and Planning System

University of Illinois at Chicago — NA

TrialNOT YET RECRUITING
Jun 2026Planning Grant for TOPS for Breast Cancer Survivors

Duke University — NA

TrialNOT YET RECRUITING
Apr 2026Effect of FB301 on Vaginal Bacterial Profile in Women With Asymptomatic Vaginal Dysbiosis Undergoing a Mock Frozen Embryo Transfer Cycle

Freya Biosciences ApS — PHASE2

TrialNOT YET RECRUITING
Apr 2026Resection and Defect Repair of Oral Cancer Aided by Mixed Reality Technology

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University — NA

TrialNOT YET RECRUITING
Apr 2026Cardiac Simulator for Surgical Planning

Stanford University — NA

TrialNOT YET RECRUITING
Apr 2026Motor Eloquent Navigated Transcranial Magnetic Stimulation for Radiosurgery Planning

Insel Gruppe AG, University Hospital Bern — NA

TrialNOT YET RECRUITING
Apr 20263D Liver Volumetry

Medical University of Graz — NA

TrialNOT YET RECRUITING
Mar 2026Bringing Medicines for HIV Prevention to a Family Planning Clinic

Women and Infants Hospital of Rhode Island — NA

TrialNOT YET RECRUITING
Feb 2026Hormonal Optimization: Late vs. Immediate Start After Discontinuation of Oral Contraceptives in Assisted Reproductive technologY (HOLIDAY)

Shady Grove Fertility Reproductive Science Center — NA

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

1 available

Lipiodol

ethiodized oil injection· Guerbet LLC■ Boxed Warning

hysterosalpingography in adults

Clinical Trials

20 recruitingView all trials with filters →
Phase 32 trials
A Study Comparing Daratumumab, VELCADE (Bortezomib), Lenalidomide, and Dexamethasone (D-VRd) With VELCADE, Lenalidomide, and Dexamethasone (VRd) in Participants With Untreated Multiple Myeloma and for Whom Hematopoietic Stem Cell Transplant is Not Planned as Initial Therapy
Phase 3
Active
PI: Janssen Research & Development, LLC Clinical Trial (Janssen Research & Development, LLC) · Sites: Cerritos, California; Jacksonville, Florida +112 more · Age: 1899 yrs
Prevention of Persistent Pain With LidocAine iNfusions in Breast Cancer Surgery (PLAN)
Phase 3
Actively Recruiting
PI: James Khan, MD (University Health Network, Toronto) · Sites: Calgary, Alberta; Edmonton, Alberta +15 more · Age: 18100 yrs
Phase 41 trial
RCT Evaluating Standardized Counseling on Early Discontinuation for Irregular Bleeding in Nexplanon Users
Phase 4
Active
PI: Colleen P McNicholas, DO, MSCI (Planned Parenthood of the St. Louis Region and Sou) · Sites: St Louis, Missouri · Age: 1840 yrs
N/A5 trials
Optimize the Support of Patients in Pelvic Onco-gynecology Through Adapted Support Care in the Post-cancer Period. AFTERGYN Pilot Phase
N/A
Active
· Sites: Caen · Age: 1899 yrs
External Oblique Intercostal Block vs Erector Spinae Plane Block for Postoperative Analgesia After Laparoscopic Cholecystectomy
N/A
Actively Recruiting
PI: Elif Sarikaya Ozel, M.D. (Karabuk Training and Research Hospital, Department) · Sites: Karabük; Samsun · Age: 1880 yrs
Post-Operative Analgesic Selection in Patients Planned for Third Molar Extraction After Undergoing Shared Decision Making Using 2- Versus 3-Option Decision-Aids
N/A
Actively Recruiting
· Sites: Newark, New Jersey · Age: 1890 yrs
Supporting Caregivers Following Mental Health Emergency Department Visits
N/A
Actively Recruiting
· Sites: Chicago, Illinois · Age: 1017 yrs
Cognitive Outcomes After Brain Substructure-informed Radiation Planning in Pediatric Patients
N/A
Actively Recruiting
PI: Sahaja Acharya, MD (Sidney Kimmel Comprehensive Cancer Center at Johns) · Sites: Washington D.C., District of Columbia; Baltimore, Maryland · Age: 126 yrs
Other11 trials
Discharge Recommendations for Older Adults Using Physical Outcome Measure
Actively Recruiting
· Sites: Singapore · Age: 6599 yrs
NON-INVASIVE BLOOD FLOW ASSESSMENT: Computational Tool for Measuring Arterial Flow From CT
Enrolling by Invitation
· Sites: Barcelona, Barcelona · Age: 1899 yrs
PLAN-A Data- Bio- and Plan- Bank Collection for SCCA in Denmark
Active
· Sites: Aarhus; Herlev +1 more · Age: 1899 yrs
Post-Market Clinical Investigation Plan - Collagen Dura Membranes (DM & DMO)
Actively Recruiting
· Sites: Milwaukee, Wisconsin · Age: 1899 yrs
Risk Informed Obesity Care Plan Pilot
Enrolling by Invitation
· Sites: Boston, Massachusetts · Age: 212 yrs
Post-Market Clinical Investigation Plan- Collagen Dural Regeneration Matrix (DuraMatrix-Onlay Plus)
Actively Recruiting
· Sites: Augusta, Georgia; Boston, Massachusetts · Age: 1899 yrs
Molecular Classification of Endometrial Cancer: Impact on Adjuvant Treatment Planning.
Active
· Sites: Thessaloniki · Age: 1880 yrs
Increasing Pre-Surgical Identification of Muscle Invasive Tumor Evaluations Prior to Planned Cystectomy (INSITE)
Actively Recruiting
PI: Alexander Kutikov, M.D. (Fox Chase Cancer Center) · Sites: Omaha, Nebraska; Philadelphia, Pennsylvania · Age: 1899 yrs
ROSA Knee Intraoperative Planning Flexibility Study
Actively Recruiting
PI: Yasuharu Nakashima (Kyushu University) · Sites: Fukuoka, Fukuoka · Age: 2099 yrs
Planning for Frailty: Optimal Health and Social Care Workforce Organisation Using Demand-led Simulation Modelling
Active
PI: Bronagh M Walsh/Professor, PhD (University of Southampton) · Sites: Southampton · Age: 5099 yrs
Safety Plan in Emergency Department to Prevent Suicidal Attempt Recidive
Active
· Sites: Paris, Île-de-France Region · Age: 1899 yrs

Specialists

Showing 25 of 61View all specialists →
QZ
Q Zhong
Specialist
2 Infantile neuroaxonal dystrophy publications
MM
Mariam M Mohsin
NORTHBROOK, IL
Specialist
1 Infantile neuroaxonal dystrophy publication
JM
José Manuel Martínez-Martos
Specialist
1 Infantile neuroaxonal dystrophy publication
SA
Shahd A Abuhijleh
Specialist
1 Infantile neuroaxonal dystrophy publication
MR
María Jesús Ramírez-Expósito
Specialist
1 Infantile neuroaxonal dystrophy publication
MG
María González-Sánchez
Specialist
1 Infantile neuroaxonal dystrophy publication
AF
Abdul Fatah
Specialist
1 Infantile neuroaxonal dystrophy publication
AF
Alian Fatima
Specialist
1 Infantile neuroaxonal dystrophy publication
MK
Manjunatha Goud Bellary Kuruba
Specialist
1 Infantile neuroaxonal dystrophy publication
BG
Biji Thomas George
BUFFALO, NY
Specialist
1 Infantile neuroaxonal dystrophy publication
RD
Rajani Dube
Specialist
1 Infantile neuroaxonal dystrophy publication
SK
Subhranshu Sekhar Kar
Specialist
1 Infantile neuroaxonal dystrophy publication
PM
Peter Milner, MD
LOS ALTOS HILLS, CA
Specialist
PI on 4 active trials
TD
Thomas Klopstock, Prof. Dr.
Specialist
PI on 3 active trials
JC
Jeremie Calais
LOS ANGELES, CA
Specialist
PI on 4 active trials
DP
Dong-Xin Wang, MD, PhD
Specialist
PI on 6 active trials
WG
Wei-da Gong
Specialist
1 Infantile neuroaxonal dystrophy publication
TZ
Tian-Tian Zhao
Specialist
1 Infantile neuroaxonal dystrophy publication
GT
Gang Tao
Specialist
1 Infantile neuroaxonal dystrophy publication
MP
Martin King, MD, PhD
BUDD LAKE, NJ
Specialist
PI on 3 active trials
MF
Martyn R Partridge, MD FRCP
Specialist
PI on 2 active trials
CM
Claire Kalpakjian, PhD, MS
Specialist
PI on 2 active trials
EE
Emine EFE
Specialist
PI on 3 active trials1 Infantile neuroaxonal dystrophy publication
AR
Anna K Radin
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Infantile neuroaxonal dystrophy.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Infantile neuroaxonal dystrophyForum →

No community posts yet. Be the first to share your experience with Infantile neuroaxonal dystrophy.

Start the conversation →

Latest news about Infantile neuroaxonal dystrophy

Disease timeline:

New recruiting trial: Hormonal Optimization: Late vs. Immediate Start After Discontinuation of Oral Contraceptives in Assisted Reproductive technologY (HOLIDAY)

A new clinical trial is recruiting patients for Infantile neuroaxonal dystrophy

New recruiting trial: Question Prompt List in Breast Cancer Patients Planned for Neoadjuvant Chemotherapy

A new clinical trial is recruiting patients for Infantile neuroaxonal dystrophy

New recruiting trial: Effects of Erector Spinae Plane Block on Opioid Consumption, Anesthetic Consumption and Hemodynamics in Lumbar Disc Herniation Surgeries.

A new clinical trial is recruiting patients for Infantile neuroaxonal dystrophy

New recruiting trial: Stem Cell Treatment for Lung Injury Caused by Major Infectious Diseases

A new clinical trial is recruiting patients for Infantile neuroaxonal dystrophy

New recruiting trial: Group Advanced Care Planning Pilot for Veterans

A new clinical trial is recruiting patients for Infantile neuroaxonal dystrophy

New recruiting trial: StandUPTV Habits: Feasibility Trial for Maintaining Reductions in Sedentary Screen Time

A new clinical trial is recruiting patients for Infantile neuroaxonal dystrophy

New recruiting trial: Prevention of Persistent Pain With LidocAine iNfusions in Breast Cancer Surgery (PLAN)

A new clinical trial is recruiting patients for Infantile neuroaxonal dystrophy

New recruiting trial: Planned Delivery at 37 Versus 36 Weeks in Pregnancies With Placenta Previaand Accreta

A new clinical trial is recruiting patients for Infantile neuroaxonal dystrophy

New recruiting trial: 177Lu-DOTATATE Modified Delivery Based on Individualized Dosimetry

A new clinical trial is recruiting patients for Infantile neuroaxonal dystrophy

New recruiting trial: Patient-Specific vs. Conventional Positioning in Sagittal Split Ramus Osteotomy

A new clinical trial is recruiting patients for Infantile neuroaxonal dystrophy

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What genetic testing should we do to confirm the diagnosis, and how long will results take?,What symptoms should we watch for that would require an emergency room visit?,What therapies or specialists should be part of our child's care team right now?,Are there any clinical trials or research studies our child might be eligible for?,When should we start talking about palliative care, and what does that involve?,How do we plan for future care needs such as feeding tubes or breathing support?,Are there patient support groups or other families we can connect with?

Common questions about Infantile neuroaxonal dystrophy

What is Infantile neuroaxonal dystrophy?

Infantile neuroaxonal dystrophy (INAD), also known as Seitelberger disease, is a rare and serious brain disorder that begins in early childhood. It belongs to a group of conditions called neurodegeneration with brain iron accumulation (NBIA). In INAD, the nerve fibers that carry signals throughout the body become damaged. Tiny abnormal swellings, called axonal spheroids, build up in the nervous system and cause it to stop working properly over time. Children with INAD usually develop normally for the first year or two of life, then begin to lose skills they had already learned. The disease af

How is Infantile neuroaxonal dystrophy inherited?

Infantile neuroaxonal dystrophy follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Infantile neuroaxonal dystrophy typically begin?

Typical onset of Infantile neuroaxonal dystrophy is infantile. Age of onset can vary across affected individuals.

Are there clinical trials for Infantile neuroaxonal dystrophy?

Yes — 20 recruiting clinical trials are currently listed for Infantile neuroaxonal dystrophy on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Infantile neuroaxonal dystrophy?

25 specialists and care centers treating Infantile neuroaxonal dystrophy are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.

What treatment and support options exist for Infantile neuroaxonal dystrophy?

1 patient support program are currently tracked on UniteRare for Infantile neuroaxonal dystrophy. See the treatments and support programs sections for copay assistance, eligibility, and contact details.